Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Cullinan Therapeutics (Nasdaq: CGEM) announced management will present at two upcoming investor conferences in early March 2026. CEO Nadim Ahmed and CMO Jeffrey Jones will appear in fireside chats at the TD Cowen 46th Annual Healthcare Conference on March 3 and the Leerink Global Healthcare Conference on March 10. Webcasts will be available under the Events and Presentations section of the company's investor relations website.

CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today announced its participation in the following upcoming investor conferences:

• Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026, at 1:10 p.m. ET.
• Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the 2026 Leerink Global Healthcare Conference on Tuesday, March 10, 2026, at 4:20 p.m. ET.

Webcasts of the fireside chats will be available under the Events and Presentations section of the Company’s investor relations website at https://investors.cullinantherapeutics.com/events.

About Cullinan Therapeutics

Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company developing potential first- or best-in-class, high-impact therapies for autoimmune diseases and cancer. Cullinan pursues promising therapeutic targets while leveraging core expertise in T cell engagers, which are established in oncology and are now advancing into autoimmune diseases. With a clinical-stage pipeline built on a rigorous scientific approach and purposeful innovation, Cullinan is advancing its mission to deliver new standards of care for patients. Learn more about Cullinan at https://cullinantherapeutics.com/, and follow Cullinan on LinkedIn and X.

Contacts:

Investors
Nick Smith
+1 401.241.3516
nsmith@cullinantx.com

Media
Rose Weldon
+1 215.801.7644
rweldon@cullinantx.com

FAQ

When will Cullinan Therapeutics (CGEM) present at the TD Cowen 2026 healthcare conference?

Cullinan will present on March 3, 2026 at 1:10 p.m. ET. According to the company, CEO Nadim Ahmed and CMO Jeffrey Jones will participate in a fireside chat, and a webcast will be available on the investor relations Events and Presentations page.

What time is the Cullinan Therapeutics (CGEM) fireside chat at the Leerink Global Healthcare Conference?

The fireside chat is scheduled for March 10, 2026 at 4:20 p.m. ET. According to the company, CEO Nadim Ahmed and CMO Jeffrey Jones will lead the session and the webcast will be posted on the company's investor relations site.

How can investors watch Cullinan Therapeutics (CGEM) conference webcasts?

Investors can watch webcasts via the company's investor relations website under Events and Presentations. According to the company, the March 3 and March 10 fireside chats will be available there for live or archived viewing.

Who will represent Cullinan Therapeutics (CGEM) at the March 2026 investor conferences?

CEO Nadim Ahmed and CMO Jeffrey Jones will represent the company at both events. According to the company, both executives will participate in fireside chats and provide updates during the TD Cowen and Leerink conferences.

Will Cullinan Therapeutics (CGEM) provide new clinical data at the March 2026 presentations?

The announcement lists fireside chats but does not specify new clinical data being presented. According to the company, the events feature executive discussions and webcasts; any data disclosure would be detailed in the presentation webcast or subsequent investor materials.

Where and when will the Cullinan Therapeutics (CGEM) conference webcasts be posted for later viewing?

Webcasts will be posted under the Events and Presentations section of the investor relations website after the live sessions. According to the company, both the March 3 and March 10 fireside chat webcasts will be available there for later access.